A carregar...
A vicious partnership between AKT and PHLDA3 to facilitate neuroendocrine tumors
Pancreatic neuroendocrine tumors (PanNET) are rare cancers that generally have a poor prognosis. Accurate diagnosis and proper treatment of these tumors requires a better understanding of the molecular mechanisms underlying the development of PanNET. It has been shown that the mTOR inhibitor everoli...
Na minha lista:
| Publicado no: | Cancer Sci |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5480075/ https://ncbi.nlm.nih.gov/pubmed/28295876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13235 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|